Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $58

Canaccord Genuity analyst William Plovanic has maintained a 'Buy' rating on Pulse Biosciences (NASDAQ: PLSE) and increased the price target from $43 to $58. This adjustment reflects a positive outlook on the company's performance.